STOCK TITAN

Leidos Holdings SEC Filings

LDOS NYSE

Welcome to our dedicated page for Leidos Holdings SEC filings (Ticker: LDOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Leidos’ filings aren’t just long—they’re layered with classified contract language, labyrinthine cost-plus fee schedules, and segment realignments that can reshape revenue overnight. If you have ever searched for “Leidos SEC filings explained simply” or wished for a shortcut to decipher a 300-page risk section, you are in the right place.

Stock Titan’s AI reads every disclosure the instant it hits EDGAR, then translates it into clear takeaways. Want the latest Leidos quarterly earnings report 10-Q filing broken down by Defense, Civil, and Health profits? Done. Need alerts on Leidos Form 4 insider transactions real-time so you can spot buying ahead of contract awards? They arrive within seconds. Our platform also surfaces:

  • Leidos annual report 10-K simplified—segment backlog drivers, classified revenue exposure, and pension obligations.
  • Leidos proxy statement executive compensation—how incentive pay ties to mission wins and cost controls.
  • Leidos 8-K material events explained—from bid protest results to cyber incident disclosures.

Every page includes AI-powered summaries, side-by-side metric comparisons, and keyword search so you can move from question to answer quickly—whether you ask, “How is Leidos funding its R&D?” or “Where do I find Leidos executive stock transactions Form 4?”

Finish research faster: track Leidos insider trading Form 4 transactions, run instant Leidos earnings report filing analysis, and keep understanding Leidos SEC documents with AI—all updated in real time and available without navigating EDGAR’s maze.

Rhea-AI Summary

OCI N.V. and its Dutch subsidiaries OCI Intermediate B.V. and OCI Chemicals B.V. have filed a Schedule 13G disclosing a sizeable passive stake in Methanex Corporation (NASDAQ/TSX: MEOH). The filing, triggered by a June 27 2025 event date, shows beneficial ownership of 9,944,308 common shares, equal to 12.9 % of Methanex’s 77,339,520 shares outstanding as of June 30 2025.

All shares are held with shared voting power over 7,726,218 shares – subject to an undertaking not to vote more than 9.99 % of the company’s outstanding stock until Toronto Stock Exchange listing conditions are satisfied – and shared dispositive power over the full 9.94 million-share position. The reporting persons possess no sole voting or dispositive authority, underscoring the filing’s passive intent. Each entity certifies that the securities were not acquired for the purpose of influencing control, in line with Schedule 13G requirements.

The disclosure makes OCI – a Netherlands-based global producer of nitrogen, methanol and hydrogen products – one of Methanex’s largest known shareholders. While the filing does not announce any transaction terms or strategic plans, the scale of the stake (worth roughly US$450-500 million at recent prices) signals institutional confidence in Methanex’s methanol market outlook and could foreshadow future collaboration or corporate activity within the global methanol value chain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Leidos Holdings, Inc. (LDOS) – Form 4 insider transaction

Chief Financial Officer Christopher R. Cage reported one transaction dated 06/30/2025.

  • Acquisition: 64.1944 shares of common stock credited at $0.00 per share. The shares represent dividend-equivalent rights that were automatically reinvested in the company’s Key Executive Stock Deferral Plan.
  • Post-transaction ownership: 29,288.682 indirect shares held via the deferral plan and 46,953 direct shares.

No derivative securities were involved and no sales were disclosed. The filing does not indicate any open-market purchases or dispositions; the recorded activity is routine and non-cash. Given the immaterial share amount relative to the executive’s existing holdings, the filing is unlikely to have a meaningful impact on LDOS’s share count or market perception.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Progress Software Corp. (PRGS) – Form 4 insider transaction

Chief Information Officer Ian Pitt reported the sale of 2,186 common shares of Progress Software on 30 June 2025 at an average price of $65.21, generating proceeds of roughly $142.6 thousand. The transaction was made under a Rule 10b5-1 trading plan adopted 24 July 2024, indicating it was pre-scheduled rather than opportunistic. Following the sale, Pitt directly owns 6,513 shares of PRGS, which include 382 shares previously acquired through the company’s Employee Stock Purchase Plan on 31 March 2025.

No derivative securities were reported in this filing, and there were no additional acquisitions or dispositions disclosed. The filing was signed by attorney-in-fact YuFan Stephanie Wang on 2 July 2025.

  • Form type: Form 4 (Statement of Changes in Beneficial Ownership)
  • Reporting person: Ian Pitt, Chief Information Officer
  • Transaction code: S (open-market sale)
  • Ownership status after sale: Direct (D)

The sale size is modest relative to typical executive transactions and represents a routine liquidity event rather than a material change in ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

GitLab Inc. (NASDAQ: GTLB) has filed a Form 144 disclosing the proposed sale of 1,214 shares of its Class A common stock under Rule 144. The shares, valued at roughly $55,249, account for less than 0.001 % of the company’s approximately 146.1 million shares outstanding, making the transaction immaterial to GitLab’s overall float and market liquidity.

The seller acquired the stock as restricted stock units (RSUs) on 27 June 2025 and intends to execute the sale through Morgan Stanley Smith Barney LLC on or after 2 July 2025. No additional sales by this filer have occurred in the past three months. The notice states that the filer is unaware of any non-public adverse information, suggesting this is a routine liquidity event rather than a signal of strategic change.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 filing summary – KeyCorp (KEY), 07/01/2025: Director Barbara R. Snyder converted 35,955 deferred shares (transaction code M) into an equal number of common shares. The conversion increased her directly held common-share position to 71,632 shares. No open-market purchase or sale price was reported because the shares derive from KeyCorp’s Directors’ Deferred Share Sub-Plan, where each deferred share is economically equivalent to a common share. Following the transaction, Snyder still holds 177,901 deferred shares that remain subject to the plan. The filing also notes that direct ownership totals include roughly 175 common shares obtained through the June 2025 dividend-reinvestment program, and deferred-share holdings include about 2,765 dividend-equivalent units accrued during the same period. As there was no disposition of shares and the transaction merely settles a long-standing equity award, the impact on KeyCorp’s public float and insider sentiment is modest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Leidos Holdings (LDOS)?

The current stock price of Leidos Holdings (LDOS) is $164.56 as of July 3, 2025.

What is the market cap of Leidos Holdings (LDOS)?

The market cap of Leidos Holdings (LDOS) is approximately 20.0B.

What are the core business segments of Leidos Holdings?

Leidos operates through three primary segments: Defense Solutions, Civil, and Health. Each segment focuses on delivering advanced technological solutions tailored to specific market needs.

Who are the primary customers of Leidos Holdings?

Leidos serves a diverse customer base including U.S. government agencies such as the Department of Defense, Intelligence Community, and various state, local, and international entities, as well as commercial organizations.

How does Leidos generate its revenue?

Revenue is generated primarily through long-term, contract-driven engagements across its defense, civil, and health segments, with a significant focus on managed services and integrated technology solutions.

What sets Leidos apart from its competitors?

Leidos differentiates itself through its deep technical expertise, comprehensive service model, and a robust track record in executing complex, mission-critical projects for heavily regulated industries.

What kinds of technological solutions does Leidos offer?

The company offers a wide range of solutions including digital modernization, cybersecurity, advanced IT integration, geospatial intelligence, and innovative engineering services designed to secure critical infrastructures.

How does Leidos support national security and health sectors?

Leidos supports these sectors by providing secure, efficient, and technologically advanced solutions that enhance operational readiness, safeguard digital and physical infrastructures, and improve health outcomes through managed services and clinical research support.

What role does innovation play in Leidos' business model?

Innovation is a cornerstone of Leidos' operations. The company continuously invests in emerging technologies, collaborates with industry partners, and refines its digital solutions to meet evolving market demands.

Does Leidos engage in strategic partnerships?

Yes, Leidos actively partners with technology leaders and industry innovators to enhance its range of services. These collaborations help integrate cutting-edge solutions into its portfolio and drive forward operational efficiencies.
Leidos Holdings

NYSE:LDOS

LDOS Rankings

LDOS Stock Data

20.04B
127.72M
0.67%
80.65%
4.47%
Information Technology Services
Services-computer Integrated Systems Design
Link
United States
RESTON